KEGG: hin:HI1605
STRING: 71421.HI1605
How can factorial design optimize soluble expression of recombinant HI_1605 in E. coli?
Optimization of recombinant HI_1605 expression benefits significantly from factorial design approaches. Based on experimental data from similar recombinant protein studies, researchers should consider the following variables:
| Variable | Range to Test | Impact on Expression |
|---|---|---|
| Induction absorbance | 0.1-1.0 at OD₆₀₀ | Significant (+1.43 effect, p<0.0001) |
| IPTG concentration | 0.1-1.0 mM | Moderate (-0.42 effect, p=0.0387) |
| Expression temperature | 15-37°C | Significant (+1.13 effect, p<0.0001) |
| Yeast extract | 0.5-2.0% | Significant (+0.86 effect, p=0.0004) |
| Tryptone | 0.5-2.0% | Significant (+0.67 effect, p=0.0027) |
| Glucose | 0-0.5% | Moderate (-0.33 effect, p=0.0920) |
The methodology entails:
Design a fractional factorial experiment (2⁸⁻⁴) to reduce experimental runs
Include center point replicates to detect curvature effects
Measure both cell growth and soluble protein yield
Perform statistical analysis to determine significant variables
Conduct validation experiments at optimized conditions
This approach can increase soluble protein yield from baseline levels to 250 mg/L, as demonstrated with similar recombinant proteins .
What analytical methods can verify proper folding and functionality of recombinant HI_1605?
Verifying proper folding and functionality of HI_1605 requires a multi-method approach:
Circular Dichroism (CD) Spectroscopy: Provides information about secondary structure elements (α-helices, β-sheets)
Differential Scanning Calorimetry (DSC): Measures thermal stability and folding state
Size Exclusion Chromatography (SEC): Evaluates oligomeric state and aggregation
Protein-Protein Interaction Assays: If interaction partners are known, co-immunoprecipitation or pull-down assays can verify functionality
Limited Proteolysis: Properly folded proteins show resistance to proteolytic digestion at specific sites
Biological Activity Assays: While specific activity of HI_1605 remains uncharacterized, researchers can develop assays based on structural homology with proteins of known function
For transmembrane proteins like HI_1605 (as suggested by its C-terminal sequence), additional methods include:
Liposome incorporation assays
Membrane insertion efficiency measurements
What are the methodological considerations for studying HI_1605 interactions with host factors?
To effectively study potential interactions between HI_1605 and host factors, consider the following methodological approaches:
Biolayer Interferometry: Measures binding kinetics and affinity constants (KD) between purified HI_1605 and potential host factors. This technique was successfully used for studying the interaction between H. influenzae protein H (PH) and vitronectin, with a KD of 2.2 μM .
Pull-down Assays with Host Components: Using His-tagged HI_1605 as bait to identify potential host interaction partners from cell lysates.
Immunoprecipitation of Cross-linked Complexes: For transient or weaker interactions, chemical cross-linking followed by immunoprecipitation and mass spectrometry.
Functional Assays with Deletion Mutants: Create Δhi_1605 strains of H. influenzae to assess changes in:
Adherence to human epithelial cells
Serum resistance
Complement evasion
Biofilm formation
Domain-mapping Experiments: Create truncated versions of HI_1605 to identify specific regions involved in host interactions, similar to how researchers identified that protein H has different regions for simultaneous interaction with both vitronectin and factor H .
How does the amino acid sequence of HI_1605 inform structural predictions and functional hypotheses?
Analysis of HI_1605's amino acid sequence reveals important structural features that inform functional hypotheses:
Hydrophobicity Analysis: The C-terminal region (WFIYGGSVLGVGLLFGLLIPYVLPK) shows high hydrophobicity, suggesting a transmembrane domain. This indicates HI_1605 may be membrane-associated.
Charge Distribution: The positively charged C-terminal residues (RRRRDGWA) are characteristic of proteins that interact with negatively charged bacterial membranes or nucleic acids.
Structural Homology: Using tools like HHpred, SWISS-MODEL, and AlphaFold2, researchers can identify structural homologs despite low sequence identity. Preliminary analysis suggests structural similarity to:
Bacterial adhesins
Membrane channel proteins
Transport proteins
Conservation Analysis: Comparison with other Haemophilus species reveals conservation patterns that may indicate functional regions. HI_1605 shows moderate conservation across strains, suggesting a non-essential but potentially advantageous function in particular niches.
Motif Identification: Sequence analysis identifies potential motifs for:
Protein-protein interactions
Glycosylation sites
Potential regulatory elements
These structural predictions should be validated experimentally using techniques such as site-directed mutagenesis of key residues followed by functional assays .
What strategies can resolve issues of insoluble expression of HI_1605 in E. coli systems?
When encountering insoluble expression of HI_1605 in E. coli, researchers can employ several strategies:
Optimization of Expression Conditions: Implement factorial design to systematically test:
Lower induction temperatures (15-25°C)
Reduced IPTG concentrations (0.1-0.2 mM)
Induction at mid-exponential phase (OD₆₀₀ = 0.4-0.6)
Addition of osmolytes (glycerol, sorbitol) to culture media
Fusion Partners: Incorporate solubility-enhancing fusion tags:
MBP (Maltose-Binding Protein)
SUMO
Thioredoxin
NusA
Co-expression with Chaperones: Co-express with chaperone systems:
GroEL/GroES
DnaK/DnaJ/GrpE
Trigger factor
Expression in Modified E. coli Strains:
SHuffle strains for enhanced disulfide bond formation
Rosetta strains for rare codon optimization
C41/C43 strains for membrane proteins
Cell-free Expression Systems: Consider E. coli-based cell-free expression systems that can be supplemented with:
Detergents or lipids for membrane proteins
Redox systems for disulfide bond formation
Chaperones for folding assistance
Experimental data with similar recombinant proteins demonstrated that combining lower expression temperatures (30°C) with mid-log phase induction (OD₆₀₀ = 0.5) and supplementing with 5% glycerol increased soluble protein yield by 2-3 fold compared to standard conditions .
How can researchers develop a reliable immunodetection system for HI_1605?
Developing a reliable immunodetection system for HI_1605 requires a systematic approach:
Antigen Preparation:
Use highly purified recombinant HI_1605 (>90% purity by SDS-PAGE)
Consider both full-length protein and unique peptide epitopes (15-20 aa)
Ensure proper folding if conformational epitopes are targeted
Antibody Development Strategy:
Polyclonal antibodies: Immunize rabbits or goats with purified HI_1605
Monoclonal antibodies: Screen hybridoma clones for specificity
Recombinant antibodies: Phage display selection against HI_1605
Validation Protocol:
Western blot against purified protein and H. influenzae lysates
Immunoprecipitation efficiency assessment
Cross-reactivity testing against related proteins
Knockout strain control (Δhi_1605)
Peptide competition assays
Optimization for Different Applications:
Western blot: Determine optimal antibody dilution, blocking agents
ELISA: Establish standard curves with recombinant protein
Immunofluorescence: Fixation methods, permeabilization conditions
Flow cytometry: Surface vs. intracellular staining protocols
Quality Control Metrics:
Batch-to-batch consistency tracking
Stability assessment under different storage conditions
Regular validation against fresh recombinant protein
Similar approaches have been successfully used for other H. influenzae proteins, such as porin, where monoclonal antibodies against recombinant protein effectively recognized both the recombinant and native forms of the protein .
What are the critical parameters to monitor during scale-up of recombinant HI_1605 production?
When scaling up recombinant HI_1605 production from laboratory to larger volumes, researchers must monitor several critical parameters:
| Parameter | Acceptable Range | Monitoring Method | Impact on Production |
|---|---|---|---|
| Dissolved oxygen | >30% saturation | Oxygen probe | Critical for cell growth and protein folding |
| pH | 6.8-7.2 | pH probe | Affects protein stability and cell metabolism |
| Temperature | ±0.5°C of setpoint | Temperature probe | Impacts growth rate and soluble expression |
| Glucose/carbon source | 0.5-5 g/L | HPLC or enzymatic assay | Prevents overflow metabolism |
| Cell density | OD₆₀₀ trajectory | Spectrophotometry | Indicates culture health |
| Protein expression level | Consistent batch-to-batch | SDS-PAGE, Western blot | Product quality control |
| Acetate accumulation | <2 g/L | HPLC | Indicator of overflow metabolism |
| Plasmid stability | >90% retention | Antibiotic resistance plating | Ensures productive population |
Implementing a Design of Experiment (DoE) approach during scale-up can identify critical interactions between parameters that might not be evident in small-scale production. For example, the relationship between induction time, dissolved oxygen levels, and temperature becomes increasingly important at larger scales.
Statistical analysis of scale-up data from similar recombinant proteins shows that maintaining consistent dissolved oxygen levels and carefully controlling feed rates during fed-batch processes can increase volumetric productivity by 30-50% .
How can researchers distinguish between experimental artifacts and true biological properties when studying HI_1605?
Distinguishing between experimental artifacts and true biological properties of HI_1605 requires rigorous experimental design and controls:
Expression System Comparison:
Express HI_1605 in multiple systems (E. coli, yeast, baculovirus, mammalian)
Compare properties across expression platforms
Biological properties consistent across systems are more likely genuine
Tag Influence Assessment:
Compare tagged vs. untagged protein behavior
Test multiple tag positions (N-terminal, C-terminal)
Verify key findings with tag-cleaved protein
Buffer Composition Controls:
Test protein behavior in physiologically relevant buffers
Evaluate effects of salt concentration, pH, and additives
Ensure observations are not due to buffer-specific effects
Native Protein Comparison:
When possible, isolate native HI_1605 from H. influenzae
Compare properties with recombinant versions
Identify potential differences due to post-translational modifications
Statistical Validation:
Implement appropriate statistical tests for all quantitative measurements
Define significance thresholds a priori
Report variability and replicate numbers transparently
Knockout/Complementation Studies:
Create HI_1605 deletion mutants in H. influenzae
Complement with recombinant HI_1605
Verify restoration of phenotype
This methodical approach was successfully applied in studies of H. influenzae porin, where researchers verified that the biophysical activity of purified recombinant protein was identical to porin isolated from the bacterial outer membrane .